MedTrace Logo

Anatomical Shoulder™ Inverse/Reverse Study

NCT02466321 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 154

Last updated 2025-06-12

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to obtain outcomes data on the Anatomical Shoulder™ Inverse/Reverse System by analysis of standard scoring systems and radiographs.

Outcome data will be collected using the following standard scoring systems of which summary statistics will be provided:

• Constant and Murley Score to evaluate clinical parameters such as range of motion, power, level of pain and functional ability.

Conditions

  • Cuff-tear Arthropathy

Interventions

PROCEDURE

Inverse/Reverse Shoulder Arthroplasty

Implantation of the Anatomical Shoulder Inverse/Reverse System

Sponsors & Collaborators

  • Zimmer, GmbH

    lead INDUSTRY

Principal Investigators

  • Elliott Goff, PhD · Zimmer Biomet, Jr. Clinical Project Lead

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-16
Primary Completion
2022-02-16
Completion
2024-03-11

Countries

  • Belgium
  • Germany
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02466321 on ClinicalTrials.gov